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Mitochondrial ribosome taggingMitochondrial translation synthesizes key subunits of the respiratory complexes. In Schizosaccharomyces pombe,
strains lackingMrf1, themitochondrial stop codon recognition factor, are viable, suggesting that other factors can
play a role in translation termination. S. pombe contains four predicted peptidyl tRNA hydrolases, two of which
(Pth3 and Pth4), have a GGQ motif that is conserved in class I release factors. We show that high dosage of
Pth4 can compensate for the absence of Mrf1 and loss of Pth4 exacerbates the lack of Mrf1. Also Pth4 is a compo-
nent of the mitochondrial ribosome, suggesting that it could help recycling stalled ribosomes.
© 2013 The Authors. Elsevier B.V. andMitochondria Research Society.Open access under CC BY license.1. Introduction
Mitochondria are essential organelles that are found in almost all
eukaryotic cells, it is generally accepted that they arose from the endo-
symbiosis ofα proteobacteria, closely related to Rickettsia, into a eukary-
otic ancestor (Emelyanov, 2003). Their main function is to provide the
cell with energy in the form of ATP, via oxidative phosphorylation
(OXPHOS), a process completed by multi-protein complexes located in
the inner mitochondrial membrane. Mitochondria contain their own
genome, which encodes a small number of key OXPHOS subunits of
the respiratory complexes, andmost or all, of the RNAs needed for mito-
chondrial translation. The vast majority of the proteins involved inmito-
chondrial translation are of nuclear origin; thus both the OXPHOS
complexes and the mitochondrial translation machinery are of dual ge-
netic origin.
Due to the endosymbiotic origin of mitochondria, many aspects of
translation resemble the bacterial system; however, there are some dif-
ferences, e.g. variations in the genetic code, the absence of a Shine-
Dalgarno type ribosome binding site (sometimes replaced by specificéculaire, CNRS Bâtiment 26, 1
nce. Tel.: +33 1 69 82 31 91;
logne, Zülpicher Str. 47a, 50674
ndria Research Society. Open access undtranslational activators), and a smaller set of tRNAs and translation fac-
tors (reviewed in Herrmann et al., 2013).
Another notable difference is that although there is some limited
transcriptional control, at least in humans where transcript levels do
not always reflect changes in mtDNA abundance, transcription is not
the principal point of regulation in mitochondria. For example, in
Schizosaccharomyces pombe Atp9 and Apt6 are encoded on the same
polycistronic primary transcript but there is a ten-fold difference in
the levels of the proteins (Deshpande and Patel, 2012). Thus the post-
transcriptional steps of mitochondrial RNA metabolism and especially
translation are important control points of mitochondrial gene expres-
sion. Consequently, mitochondrial translation defects are a frequent
cause of human diseases, both because this is a crucial step in respirato-
ry complex biogenesis and because there are many mitochondrial and
nuclear genes involved in the mechanism and regulation of translation.
Mutations causingmitochondrial diseases have been identified inmito-
chondrial genes encoding ribosomal RNAs (rRNA) and transfer RNAs
(tRNA), and also in a number of nuclear genes encoding mitochondrial
ribosomal proteins (MRPs), aminoacyl tRNA synthetases, tRNA modifi-
cation enzymes, and translation factors (Ylikallio and Suomalainen,
2012). Among the general translation factors, disease causingmutations
have been found in elongation factors, such as mtEF-Tu, mtEF-Ts and
mtEFG1, and more recently a mutation was identified in C12orf65, a
predicted peptidyl tRNA hydrolase thought to act in translation termi-
nation and thus tRNA recycling (Antonicka et al., 2010).
Peptide release from the ribosome is an essential part of the normal
termination of translation, but it is also needed to unblock stalleder CC BY license.
Table 1
S. pombe strains used in this work.
Strain name Genotype Reference
NB205-6A h− ade6-M216 ura4-D18 his3Δ leu1-32 Chiron et al. (2005)
NB34-21A h− ade6-M216 ura4-D18 his3Δ leu1-32 ptp1-1 Chiron et al. (2005)
NBp9-725 h+ ade6-M216 leu1-32 This work
NB204-14B h− ade6M-210, his3Δ This work
CHP056 h+ ade6-M216 leu1-32 mrp4-His7::kanR This work
CHP056-2A h− ade6M-210 his3Δmrp4-His7::kanR This work
CHP060 h+ ade6-M216 leu1-32 mrpl12-His7::kanR This work
CHP060-2D h+ ade6 leu1-32 mrp4-His7::kanR
mrpl12-His7::kanR
This work
LD63-1 h+ ade6 mrp4-His7::kanR mrpl12-His7::
kanR leu1::pth3-FLAG2-His6
This work
LD64-1 h+ ade6 mrp4-His7::kanR mrpl12-His7::
kanR leu1::pth4-FLAG2-His6
This work
LD65-1 h+ ade6 mrp4-His7::kanR mrpl12-His7::
kanR leu1::mrf1-FLAG2-His6
This work
KV8-7 h− ade6-M216 ura4-D18 his3Δ
leu1-32 Δpth3::kanR
This work
NB338-1D h+ ura4-D18 leu1-32 Δpth3::kanR This work
MG49-17 h− ade6-M216 his3Δ leu1-32 ura4-D18
Δpth4::kanR
This work
MG50-12 h− ade6-M216 leu1-32 ura4 ptp1-1
Δpth4::kanR
This work
MG50-24 h− ade6-M216 leu1-32 ura4 ptp1-1
Δpth4::kanR
This work
LD1-2A h? ade6 ura4-D18 leu1-32 Δpth3::kanR This work
LD1-2B h? ura4-D18 his3Δ leu1-32 Δpth3::kanR
Δpth4::kanR
This work
LD1-2C h? ade6 ura4-D18 leu1-32 This work
LD1-2D h? ura4-D18 his3Δ leu1-32 Δpth4::kanR This work
NB329-1 h− ade6-M216 his3Δ leu1-32 ura4-D18
Δmrf1::kanR
Soleimanpour-
Lichaei et al. (2007)
NB349-6D h+ leu1-32 his3Δ Δmrf1::kanR This work
NB334-5C h+ ade6 ura4 leu1-32 ptp1-1 Δmrf1::kanR This work
LD5-4A h? leu1-32 his3Δ Δpth3::kanR Δmrf1::kanR This work
LD7-1B h? ura4 leu1-32 Δpth4::kanR Δmrf1::kanR ptp1-1 This work
LD7-3B h? ura4 leu1-32 Δpth4::kanR Δmrf1::kanR ptp1-1 This work
LD7-4A h? ura4 leu1-32 Δmrf1::kanR ptp1-1 This work
LD7-4B h? ade-M216 ura4 leu1-32 ptp1-1 This work
LD7-4C h? ade-M216 ura4 leu1-32 Δpth4::kanR ptp1-1 This work
LD7-4D h? ura4 leu1-32 pth4::kanR Δmrf1::kanR ptp1-1 This work
LD8-9A h? ura4 leu1-32 pth4::kanR Δmrf1::kanR ptp1-1 This work
CHP079-6C h? ade6M mrps4-His7::kanR mrpl12-His7::kanR
Δmrf1::kanR leu1::pth4-FLAG2-His6
This work
All strains contain 3 mitochondrial introns.
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cated mRNA. It is clear that the cell has evolved a variety of release fac-
tors and mechanisms to deal with these different situations. Typically,
eubacteria contain two class I release factors, RF1 and RF2, that between
them are able to recognize the three stop codons (UAA, UAG and UGA),
as well as a class II release factor, RF3, that hydrolyzes GTP to stimulate
the removal of RF1 and RF2 from the ribosome and initiate ribosome
recycling (for review Duarte et al., 2012). In addition, bacteria like
Escherichia coli contain at least three distinct systems to process stalled
ribosomes: the tmRNA encoded by ssrA that initiates trans translation
leading to termination, the peptidyl tRNA hydrolases Pth and YaeJ and
finally ArfA, which recruits RF2 to stalled ribosomes (Chadani et al.,
2011, 2012; Singh and Varshney, 2004).
The situation appears to be simpler in mitochondria, for example
there is only a single class I mitochondrial release factor (Mrf1 in yeast,
mtRF1a in humans) recognizing all yeast and human mitochondrial
stop codons (UAA and UAG) (Pel et al., 1992; Soleimanpour-Lichaei
et al., 2007; Temperley et al., 2010). To unblock stalled ribosomes mito-
chondria appear only to have peptidyl tRNA hydrolases (Antonicka et al.,
2010; Richter et al., 2010), although recentlymtRF1, a sequence homolog
of mtRF1a, has also been proposed to play a role in this process (Huynen
et al., 2012).
The yeast S. pombe sharesmany characteristicswith human cells and
is a pertinent unicellular model to study the relationships between mi-
tochondrial translation termination factors and the Pth proteins. First
S. pombe is a petite-negative yeast, dependent uponmitochondrial func-
tion (Bulder, 1964). It has a compactmtDNA, like human organelles, and
consequently S. pombe mitochondrial mRNAs have very short 3′ UTR
extensions, again similar to human mitochondrial mRNAs. In addition
S. pombe uses a set of mitochondrial translation factors very similar to
that of human mitochondria (Chiron et al., 2005). Among these, the ri-
bosome recycling factor Rrf1 and the stop codon recognition factor
Mrf1 can be replaced by their human homologs (Rorbach et al., 2008;
Soleimanpour-Lichaei et al., 2007). Finally, neither the deletion of the
mrf1 gene in S. pombe, nor the depletion of the human gene leads to a
complete block in mitochondrial protein synthesis, suggesting that
other proteins with an overlapping function exist.
We have searched for predicted peptidyl tRNA hydrolases from
S. pombe and found Pth3 and Pth4, which are sequence homologs for
the human proteins C12orf65 and ICT1 respectively. In this paper, we
have investigated the relationships between the S. pombe pth genes
andmrf1 and we find that pth4 plays an overlapping role withmrf1.
2. Materials and methods
2.1. Strains, plasmids, media and genetic methods
All the strains used in this study are described in Table 1 and were
grown at 28 °C or 36 °C as indicated. Plasmids used or constructed dur-
ing thisworkwere derivatives of pGEM-T-easy (Promega), pDUAL-FFH1,
pDUAL-YFH1 (Matsuyama et al., 2004), pTG1754/Not (Bonnefoy et al.,
1996) and pSC49 (a leu1 version of pTG1754, S. Chiron unpublished).
Genes cloned in pDUAL-FFH1 will give rise to proteins that are tagged
FLAG2His6. The human ICT1 and C12orf65 ORFs lacking the start codon
were cloned into pSC49 fused to the Neurospora crassa F0-ATPase
subunit 9 presequence and a C-terminal FLAG tag was added (Rojo
et al., 1995). Media and genetic methods were as described in
Bonnefoy et al. (1996, 2000). S. pombe asci were microdissected directly
from the mixture of haploid, diploid and sporulating cells.
HEK293-Flp-In™T-REx™ cells (HEK293T) were from Invitrogen
and were grown in Dulbecco's modified Eagle's medium with pyruvate
and L-glutamine, supplemented with 1× non-essential amino acids,
50 μg/ml uridine and 10% fetal bovine serum; untransfected cells were
routinely cultured with 10 μg/ml blasticidin and 100 μg/ml zeocin.
Cells were transfected at ~30% confluency as described in Rorbach et al.
(2008).2.2. S. pombe transformation
S. pombe cells were transformed either by a chemical method or by
electroporation. The lithium acetate technique (Okazaki et al., 1990)
was improved by (1) using single stranded salmon spermDNA as carrier,
(2) regenerating cells in complete liquidmediumovernight, and (3) plat-
ing onto 5% glucose selective medium as described in Chiron et al.
(2007). The electroporation protocol was based on several published
procedures (Suga and Hatakeyama, 2001, 2009; Suga et al., 2000,
2004). Cells were grown in YNB from Difco with 2% glucose and supple-
ments at 150 μg/ml to a density of about 1 × 107 cells/ml. Cells were
harvested by centrifugation at 4500 rpm for 5 min and resuspended in
0.1 volumes of 0.6 M sorbitol, 25 mMDTT, and 20 mMHEPES pH 7.0, in-
cubated at 30 °C for 15 min and washed 3 times with 30 ml of ice cold
1 M sorbitol. The final cell pellet was resuspended at 10 × 109 cells/ml
in 1 M sorbitol. At this point aliquots of 50 μl were used directly for elec-
troporation, or 50 μl aliquots were frozen and stored at −80 °C. For
transformation, aliquots of frozen cells were rapidly thawed in a water
bath at 30 °C, centrifuged for 1 min at 5000 rpm, resuspended in 1 ml
of ice cold 1 M sorbitol, centrifuged for 1 min at 5000 rpm and
resuspended in ice cold 1 M sorbitol to give 50 μl. Up to 5 μl of DNA in
H2Owas added to the cell suspension. Immediately after electroporation
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was incubated at 30 °C for 10 min, after which 0.2 ml aliquots were
plated directly on selective medium. When constructing gene replace-
ments and gene fusions using an antibiotic resistancemarker it is prefer-
able to allow 3–5 h of growth in rich glucose medium before plating on
the selectivemedium.With 10 ng of plasmidDNA the transformation ef-
ficiency is routinely 1–2 × 104 transformants per μg of DNA.
2.3. Construction of gene deletions in S. pombe
S. pombe gene deletionswere constructed by the PCRmethod (Wach,
1996) using pFA6a-kanMX4 (carrying the kanR gene that confers G418
resistance, Wach et al., 1994). PCR fragments containing the kanR gene
were generated with hybrid oligonucleotides containing 75 to 80 bases
of homologywith the recipient locus on both sides of the gene of interest
and transformed into NB205-6A or NB34-21A as described in Chiron
et al. (2007). [KanR] transformants able to grow in the presence of the
drug G418 were streaked again on selective medium, and the genomic
DNA of single colonies was extracted (Hoffman and Winston, 1987)
and analyzed by PCR to look both for the correct insertion of the deletion
cassette and the absence of the wild type sequences. Colonies carrying
the deletion were back-crossed to a wild type strain to verify the co-
segregation of the G418 resistance with the gene deletion.
2.4. Construction of double mutants
To construct the various double mutants, single mutants were
first crossed with a wild type to isolate spores of the opposite mating
type: NB349-6D was an h+ spore from the Δmrf1 strain NB329
(Soleimanpour-Lichaei et al., 2007), NB334-5C was an h+ spore from
the Δmrf1 ptp1-1 strain NB330 and NB338-1D was an h+ spore from
the Δpth3 strain KV8-7. Then, NB349-6D was crossed with KV8-7 to
generate the LD5-4A Δmrf1 Δpth3 double mutant, NB334-5C was
crossed with MG50-12 and MG50-24 to generate the ptp1-1 Δmrf1
Δpth4 strains LD4-3B, 4C, 4D and LD8-9A respectively, and NB338-1D
was then crossed with MG49-17 to generate the LD1-2B Δpth3 Δpth4
double mutant.
2.5. Epitope tagging of the mitochondrial ribosomal protein genes
The genes encoding proteins from the small (Mrp4) or large
(MrpL12) ribosomal subunitswere epitope tagged at their chromosomal
locus using a PCR strategy similar to that of the gene deletion (Wach,
1996), except that the forward primer contained an in-frame His7 tag
coding sequence and pFA6a-13Myc-kamMX6 was used as the template
in order to provide the terminator sequences (Petracek and Longtine,
2002). The initial gene fusions were made in NBP9-725 by integrative
transformation of PCR fragments. The constructions were verified by
PCR amplification of the 5′ section of the gene and the His7 tag and se-
quencing. The expression of the tagged protein was then verified by
western blotting of whole cell extracts. CHP056 (producing Mrp4-
His7), was crossed to NB204-14B and sporulated to give CHP056-2A,
which has the opposite mating type; this was crossed to CHP060 (pro-
ducing MrpL12-His7) and sporulated to give the doubled tagged strain
CHP060-2D.
2.6. Integration of FLAG versions of the pth and mrf1 genes
Plasmids containing the tagged S. pombe pth3, pth4 and mrf1 genes
under the control of the nmt1 promoter (Matsuyama et al., 2006) were
purchased from the RIKEN consortium and tested for their ability to
complement the corresponding mutants or the double Δpth3 Δpth4
mutant by transformation and selection for the ura4marker to maintain
the plasmid in its replicative form. The tagged genes Pth3-YFP-FLAG-
His6 and Pth4-YFP-FLAG-His6 were able to complement the respective
deletions but the RIKEN construct producing the Mrf1-YFP-FLAG-His6protein carried several mutations and did not complement. To circum-
vent this problem, the Mrf1-YFP-FLAG-His6 plasmid was reconstructed
by gap-repair, after PCR amplification of the mrf1 ORF from genomic
DNA. The complementing plasmids were cut by NotI and transformed
into the corresponding Δpth3, Δpth4 or Δmrf1 mutants to integrate the
tagged version into the leu1 locus (see Matsuyama et al., 2004), or in
the CHP60-2D strain containing His7 tagged versions of Mrp4 and
MrpL12.
2.7. Purification of mitochondria, alkali treatment, immunoprecipitation
and western blotting
Mitochondria were purified from S. pombe cells grown in complete
glucose medium as described previously (Chiron et al., 2007). Alkali car-
bonate extraction to separate membrane and solublemitochondrial frac-
tions were performed on purified mitochondria as described in Lemaire
and Dujardin (2008). Mitochondria were purified from HEK293T cells
as described in Rorbach et al. (2008). For immunoprecipitation purified
mitochondria were treated with DNase 1 and proteinase K to minimize
unspecific contamination fromcytosolic proteins, lysed and treated as de-
scribed in Rorbach et al. (2008). Protein sampleswere separated on 10 or
12% SDS-PAGE before western blotting. Primary antibodies were: anti-
Saccharomyces cerevisiae Arg8: 1/4 000 (Steele et al., 1996); anti-S.
pombe Cox2, 1/2 500 (Gaisne and Bonnefoy, 2006); anti-FLAG, 1/1 000
(Sigma F185); anti-His 1/5 000 (Genscript); anti-MRPL3, 1/2 000, anti-
MRPL12 1/1 000, anti-DAP3 1/1 000 (Abcam); anti-MRPS18B 1/4 000,
and anti-ICT1 1/800 (Proteintech Group). Secondary antibodies were di-
luted 1/10 000.
2.8. Ribosome analysis
For S. pombe, cells were grown to an OD600 of 1–1.5 in complete or
minimal glucose medium as required; the cells were then washed and
resuspended in 2× the pellet volume of lysis buffer (1% Triton X-100,
20 mM Hepes pH7.6, 40 mM KCl, 1 mM PMSF, 1× protease inhibitors
(Roche) and either 50 mM EDTA or 50 mM MgCl2), then broken under
freezing conditions using a French Press. The cell extracts were allowed
to thaw on ice and then clarified by centrifugation at 15,000 rpm and
4 °C for 10 min. The extracts (10 OD260 units) were layered onto 10 to
45% sucrose gradients in lysis buffer (25 mM KCl) containing either
EDTA or MgCl2 and centrifuged at 39,000 rpm and 4 °C for 3.5 h in a
SW41 rotor (Beckman). Gradient analysis was performed using an Isco
Foxy R1 fractionator and continuously monitored at 254 nm. Typically,
30 fractions were collected. For subsequent western blot analysis the
samples were treated as described in Daugeron et al. (2011).
For theHEK293T cell line, cellswere harvested andwashed oncewith
PBS, resuspended in lysis buffer (50 mM Tris–HCl pH 7.5, 150 mMNaCl,
10 mMMgCl2, 1% Triton X-100, 1 mMPMSF and Roche EDTA free prote-
ase inhibitor cocktail), 50 μl of cold lysis buffer for 10 mg of wet cell pel-
let. Samples were incubated on a rotating wheel for 30 min at 4 °C prior
to centrifugation at 12,000 g at 4 °C for 10 min. For the ribosome analy-
sis, 700 μg of cleared cell lysate was separated on 10–30% isokinetic
sucrose gradient.
2.9. Southern blot analyses
Total DNAs from cells grown in complete glucose medium were
extracted as described previously (Hoffman and Winston, 1987) and
electrophoresed on a 1% agarose gel before transfer onto Hybond-C
extra membranes. The blots were hybridized overnight at 65 °C under
standard saline conditions and after washing, were exposed for a few
hours, or up to 2 weeks. The probes used were the complete S. pombe
mtDNA cloned in pBR322 (del Giudice et al., 1983) labeled by nick-
translation with dATP32 (Amersham) and the 1.8 kb HinDIII fragment
of ura4 (Grimm et al., 1988) labeled with dCTP32 using a random prim-
ing kit (Invitrogen).
Cox2 Sp
His
Pth4-His6Pth3-His6 Mrf1-His6
M CM CM C
Arg8 Sc
A
P S P S P S
Cox2 Sp
Arg8 Sc
His
B
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S. pombe cells were grown to early exponential phase in minimal 5%
raffinose medium containing 0.1% glucose. Mitochondrial proteins were
labeled at 30 °C by a 3 hour incubation of whole cells with 35S methio-
nine and cysteine (Bioactif-Hartmann) in the presence of 10 mg/ml
cycloheximide (5 mg per reaction) that specifically blocks cytosolic
translation. Proteins were extracted as described in Gouget et al. (2008)
and samples were separated on 16% acrylamide–0.5% bisacrylamide
SDS gels. After drying the gel was exposed to a film for one day or up to
several weeks at −70 °C, or to a phosphorimager screen at room
temperature.
2.11. Cytochrome spectra
Low temperature cytochrome spectra of S. pombe frozen cell pastes
were recorded using a Cary 400 spectrophotometer after addition of so-
dium dithionite to fully reduce the cytochromes (Claisse et al., 1970).
The absorption maxima were 603, 560, 554 and 548 nm for cyto-
chromes aa3, b, c1 and c respectively. The S. pombe cytochrome c peak
always shows a 544 nmshoulder that disappears in a cytochrome cmu-
tant (N. Bonnefoy, data not shown).
3. Results
3.1. Localization of Mrf1, Pth3 and Pth4
In an attempt to further our understanding of the termination of mi-
tochondrial translation in S. pombe, we decided to investigate the role of
the mitochondrial Pth proteins and their possible interaction with the
mitochondrial release factor, Mrf1. Pth proteins are ubiquitous in nature
and are divided into several families, Pth1 are found in bacteria (Brun
et al., 1971) and Pth2 are found in archaea (Rosas-Sandoval et al.,
2002). Eukaryotes contain two other Pth proteins that have been
given various names (Pth3 and Pth4 in yeasts) and are related to themi-
tochondrial release factors. Crystallographic studies of the eubacterial
release factors, RF1 and RF2, in complex with the 70S ribosome show
that the glutamine residue in a conserved GGQ motif is positioned in
such a way that it can contribute directly to the hydrolysis of the
peptidyl-tRNA bond (Laurberg et al., 2008 and Weixlbaumer et al.,
2008). Fig. 1 shows an alignment of this region of Mrf1, Pth3 and Pth4
from S. pombe and the equivalent proteins from humans; it is clear
that the GGQ motif is conserved in all these proteins (a full alignment
of these three proteins from S. cerevisiae, S. pombe and humans is
shown in Fig. S1). Themechanismof action of the Pth1 andPth2 families
is different from that of the mitochondrial release factor family and do
not depend on a GGQ motif; we have deleted pth1 and pth2 and been
unable to detect any respiratory phenotype (data not shown). These re-
sults and the sequence comparisons led us to focus our study on Pth3,
Pth4 and Mrf1.
First we decided to determine the localization of the three proteins
Mrf1, Pth3 and Pth4; to do this strains carrying triple tagged versions
of the corresponding genes under the control of the thiamine repress-
ible nmt1 promoter were constructed as described in the MaterialsFig. 1.Multiple alignment of part of Mrf1 from S. pombe and mtRF1a from humans with
the S. pombe Pth3 and Pth4 proteins and their human orthologs, C12orf65 and ICT1. The
alignment was made using the full-length protein sequences and the ClustalW and
Boxshade programs from the http://www.ch.embnet.org server as for Fig. S1, but only
the region containing the GGQ motif is shown. Pth3: Spbc1105.18c; Pth4: Spac589.11.and methods. Mitochondria were purified from these strains by cell
fractionation and the mitochondria and post-mitochondrial superna-
tants were analyzed by western blot. The results, in Fig. 2A, show that
all three proteins were only found in themitochondrial fraction. To fur-
ther refine the localizations, purified mitochondria were treated with
alkaline carbonate, which will solubilize proteins that are loosely at-
tached to themembrane. Fig. 2B shows that like the integral membrane
protein Cox2, Pth3 and Pth4 were found uniquely in the membrane
fraction, whereas Mrf1 partitioned between the membrane and soluble
fraction. ThusMrf1, Pth3 and Pth4 are all mitochondrial proteins, more-
or-less tightly associated with the inner mitochondrial membrane.
However, it is not possible to know if this membrane association is di-
rect, or via their participation in a protein complex that ismembrane as-
sociated, possibly the mitochondrial ribosome.3.2. Deletion of pth3 and pth4
To determine if Pth3 and Pth4 have an important role in mitochon-
drial biogenesis the corresponding genes were deleted, the double mu-
tant Δpth3, Δpth4 was constructed and the effect of the mutations on
respiratory growth was examined. In S. pombe, an inability to grow on
galactose indicates a strong respiratory deficiency (Chiron et al.,
2007). Fig. 3A shows that all the deletion strains were able to grow on
galactose. On glycerol/ethanol medium, the deletion of pth4 had no ef-
fect, but the deletion of pth3 led to a slight reduction in growth, while
the double deletion showed a clear reduction in respiratory growth.
Low temperature cytochrome spectra of cell pastes (Fig. 3B) showed
that the Δpth4 strain had a wild type cytochrome spectrum, the Δpth3
strain showed a very slight diminution in the level of cytochrome aa3
and this was accentuated in the Δpth3, Δpth4 double mutant. Taken to-
gether, these results show that Pth3 and Pth4 are not essential forPth4-His6Pth3-His6 Mrf1-His6
Fig. 2.Mitochondrial localization andmembrane association of Pth3, Pth4 andMrf1.Mito-
chondria were purified from cells engineered to produce His6-tagged versions of Pth3,
Pth4 or Mrf1 (LD63-1, LD64-1 and LD65-1 respectively) at their chromosomal loci.
A. The post-mitochondrial supernatant corresponding to the cytosolic fraction (C) and pu-
rified mitochondria (M) were loaded on a 15% polyacrylamide gel and analyzed by west-
ern blotting with antibodies recognizing the His6-tag, the S. pombe Cox2 protein and the
S. cerevisiaeArg8 protein. In S. pombe anti-Arg8 detects both Arg1, the S. pombemitochon-
drial Arg8 homolog, and an unknown cytosolic protein. An equal amount of protein
(50 μg) was loaded in each lane. B. Purified mitochondria were alkali-treated to separate
the soluble (S) and membrane fraction (P), the total protein in each fraction was loaded
on a 15% polyacrylamide gel and analyzed by western blot as in panel A.
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Fig. 3. Phenotypic and spectral analysis of the pth gene deletions. The growth and cyto-
chrome spectra were analyzed for a tetratype issued from the cross between a Δpth3
and a Δpth4 mutant. A. Serial ten-fold dilutions of overnight cultures were spotted onto
complete medium containing the indicated carbon sources. Galactose and glycerol are
both used to reveal respiratory growth defects in S. pombe. Photographs were taken
after 5 (glucose), 8 (galactose) and 10 (glycerol/ethanol) days. B. Cells grown for 2 days
on complete glucose medium were used to record low-temperature cytochrome spectra
after fully reducing the cytochromes with dithionite. The peaks corresponding to cyto-
chrome aa3, b, c1 and c are indicated.
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Fig. 4. Interactions between pth3 and pth4, and mrf1. Δmrf1 cells were crossed to Δpth3
and Δpth4 cells and tetrads were dissected to isolate double mutants. The Δmrf1 and
Δpth4 cross was performed in the ptp1-1 background, which allows the loss of the mito-
chondrial DNA. A. Growth of serial 10 fold dilutions of the wt, single mutants and double
mutants on glucose and galactose media. B. Photograph of the germination of a tetrad
corresponding to a tetratype. C. Serial ten-fold dilutions of cultures from the tetrad in B
were spotted on completemediumcontaining glucose or galactose asmain carbon source.
D. Southern blot analysis of various ptp1-1 strains: wild type, single mutations and three
Δmrf1, Δpth4 double mutations. Genomic DNAs were extracted, digested with HinDIII
and hybridized successively with the full mitochondrial DNA cloned in pBR322, or with
the nuclear gene, ura4. The right panel corresponds to an overexposure of the blot probed
with the mitochondrial DNA. The DNA marker (Raoul I, Appligène, Strasbourg, France)
hybridizeswith pBR322 sequences. Sizes of the detectedmtDNA fragments are the follow-
ing: 4314, 4077, 3403, 2455, 2114, 1651 and 1156 bp. The HinDIII ura4 gene fragment is
1.8 kb long.
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chondrial biogenesis, which are more visible on complex IV.
3.3. Interactions between pth3 and pth4, and mrf1
In S. pombe, the deletion ofmrf1 does not lead to a complete respira-
tory deficiency (Soleimanpour-Lichaei et al., 2007), so we decided to
see if Pth3 or Pth4 had some functional overlap with Mrf1. To do this
we looked at the effect on respiratory growth of deleting or over-
expressing pth3 and pth4 in a Δmrf1 background.
The Δpth3, Δmrf1 double mutant was constructed by crossing the
two single mutants and has the same respiratory phenotype as the
Δmrf1 mutant (Fig. 4A). However, when the Δpth4 and Δmrf1 strains
were crossed, no viable double mutants were obtained; whenever
Δpth4, Δmrf1 double mutants were expected in a tetrad, we observed
micro-colonies that were unable to grow further, suggesting that
Δpth4 and Δmrf1 are co-lethal. This phenotype was reminiscent of the
deletion of the mitochondrial elongation factor mtEF-Tu, which is es-
sential formitochondrial translation (Chiron et al., 2005). To circumvent
this problem, we introduced the Δpth4 and Δmrf1 mutations into a
ptp1-1 background, which allows S. pombe to survive the loss of its mi-
tochondrial genome (rho0) and therefore a loss of mitochondrial trans-
lation (Haffter and Fox, 1992). The results in Fig. 4B and C show that in
the ptp1-1 background we could obtain Δpth4, Δmrf1 double mutants,
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Fig. 5. Pth4 is a high copy suppressor of Δmrf1. A. Δmrf1 cells were transformed with the
S. pombe pth3, or pth4 cloned in pDUAL-FFH1, giving rise to proteins that are tagged FLAG2-
His6, or their human sequence homologs C12orf65 or ICT1 that also incorporated a FLAG
tag, or with the empty vector pSC49. The growth of the transformants was compared to
that of the wild type by spotting ten-fold serial dilutions of each strain onto minimal
medium lacking leucine or complete galactose medium supplemented with 0.1% glucose.
The plates were incubated for 7 and 10 days respectively. B. Mitochondrial proteins from
the first four strains of panel A were labeled with [35S] cysteine and methionine in the
presence of cycloheximide and separated on a 16% polyacrylamide gel. An autoradiograph
of the full dried gel is presented, as well as a portion of the Coomassie blue stained gel to
serve as a loading control.
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an absence of growth on galactose.
In S. cerevisiae it is well known that mitochondrial translation is es-
sential for the maintenance of the mitochondrial genome (reviewed in
Contamine and Picard, 2000), and in S. pombe ptp1-1 strains lacking
mtEF-Tu show a strong depletion in their mitochondrial genome
(Chiron et al., 2005). We decided to use Southern blotting to examine
the level of the mitochondrial DNA in three independent Δpth4, Δmrf1
double mutants in the ptp1-1 background, and they were compared to
the isogenic wild type and the single mutants. Fig. 4D shows that the
threeΔpth4,Δmrf1 doublemutants present different levels ofmitochon-
drial DNA, varying from essentially wild type to almost undetectable,
suggesting that the Δpth4, Δmrf1 double mutation leads to a depletion
in the mitochondrial DNA and that the three samples are at different
stages of depletion. Whatever the level of depletion, the growth pheno-
types of all the double mutants are identical to that shown in Fig. 4C.
As the deletion of pth4 considerably exacerbates the Δmrf1 pheno-
type, we decided to determine if over-expression of pth3 or pth4 could
improve the respiratory competence of the Δmrf1 strain. From the re-
sults in Fig. 5A, it is clear that over-expression of pth3 has no effect on
the Δmrf1 phenotype, but over-expression of pth4 significantly im-
proves the respiratory growth of the Δmrf1 strain. To find out if this ef-
fect was due to a modification of mitochondrial translation, we looked
at de novo mitochondrial protein synthesis in the same strains, as de-
scribed in the Materials and methods, and the results are shown in
Fig. 5B. For reasons that are unclear, neo-synthesized Cytb is often low
in wild type S. pombe strains (Kühl et al., 2011). These results show
that with the exception of Cytb, the deletion ofmrf1 causes a severe re-
duction in all the de novo synthesized mitochondrial proteins. This pat-
tern of synthesis is not affected by the over-expression of pth3, but the
over-expression of pth4 significantly increases the neo-synthesis of all
the mitochondrial translation products, compared to the Δmrf1 strain.
Taken together, the results in Figs. 4 and 5 show that there is an
overlap of function between pth4 and mrf1 and that this affects the
level of the de novo synthesis of the mitochondrial proteins.
3.4. Association of the Pth proteins with the ribosome
It iswell known that release factors interact transientlywith the large
subunit of the ribosome (for a review see Youngman et al., 2008). Con-
sidering the interactions between pth3 and pth4, and pth4 and mrf1 we
decided to investigate whether the Pth proteins are associated with the
mitochondrial ribosome. To do this triple tagged versions of pth3 and
pth4 (YFP-FLAG-His6) under the control of the thiamine repressible pro-
moter nmt1 were integrated into CHP060-2D (mrp4-His7, mrpl12-His7)
at the leu1 locus as described in the Materials and methods. Whole cell
extracts were fractionated on sucrose gradients (10–45%) in the pres-
ence of EDTA,whichwill favor the dissociation of the ribosomal subunits,
or MgCl2, at concentrations that will stabilize the assembled ribosome.
Samples were collected and western blots were probed with anti-His6
antibodies to reveal Pth4 as well as Mrp4 and MrpL12, which are
markers of the small and large ribosomal subunits respectively. As the
experiments were performed on whole cell extracts, the absorbance
peaks at 254 nm are due to the cytosolic rRNAs, which are far more
abundant than the mitochondrial rRNAs; however, because of the level
of resolution of the gradients we would expect the cytosolic and mito-
chondrial rRNAs to be present in essentially the same fractions, as indi-
cated by the ribosomal marker proteins. In the presence of EDTA, we
do not detect any assembled ribosomes and Pth4 co-sediments with
the large ribosomal subunit, indicated by the presence of MrpL12. In
the presence of MgCl2, we see some unassembled small ribosomal sub-
units, no unassembled large subunits and assembled ribosomes, indicat-
ed by the position of Mrp4 and MrpL12; in this case, Pth4 co-sediments
with the assembled ribosomes (Fig. 6). This experiment was repeated
using a strain where mrf1 was deleted and Pth4 still co-sedimented
with the assembled ribosomes (Fig. S2). Similar results were obtainedfor Pth3 in a wild type background (Fig. S3). Thus both Pth3 and Pth4
co-sediment with the large ribosomal subunit and assembled ribosomes
and at least in the case of Pth4, this is not dependent on the presence of
Mrf1, suggesting that like release factors, they are associated with the
large ribosomal subunit.
%54%01
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Mrp4-His7Pth4-His6
MrpL12-His7
B
Mrp4-His7Pth4-His6
MrpL12-His7
%54%01
Total RNA
Total RNA
Fig. 6. Sucrose gradient analysis of Pth4 in whole cell extracts. Whole cell extracts from the strain LD64-1 producing Pth4-His6, as well as Mrp4-His7 and MrpL12-His7 were made in the
presence of EDTA, which favors ribosome dissociation (A) and in the presence of 50 mMMgCl2, which favors subunit association (B). These extracts were layered onto 10 to 45% sucrose
gradients. Thirty fractionswere collected after centrifugation. The absorbance trace at 254 nm, corresponding to total RNA is shown, as well as a western blot analysis of the fractionswith
an anti-His6 epitope antibody, which can recognize all three tagged proteins. Note that a longer exposure is generally needed to detect MrpL12-His7.
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In humans there are orthologs of Pth3 and Pth4, termed C12orf65
and ICT1 respectively. Initially, we decided to see if C12orf65 and ICT1
could alleviate the phenotype of the Δmrf1 mutant, to do this each
ORF was fused to the N. crassa F0-ATPase subunit 9 presequence and
cloned into a yeast expression vector and then transformed into a
Δmrf1 strain. The results in Fig. 5A show that expression from either
construct was unable to improve the respiratory growth of the Δmrf1
strain.
Next we decided to determine if Pth4 is able to associate with the
human mitochondrial ribosome. For this, the pth4 ORF was cloned
with, or without the N. crassa F0-ATPase subunit 9 presequence and
with a C-terminal FLAG epitope, into an integration vector that was
used to transfect tetracycline inducible HEK293T cells. The cells carrying
these constructs were tested for the expression of the FLAG epitope.
Cells transfected with the construct lacking the N. crassa F0-ATPase
subunit 9 presequence showed a very low level of Pth4-FLAG expres-
sion and no mitochondrial import, whereas cells carrying the construct
with theN. crassa F0-ATPase subunit 9 presequence showed a high level
of Pth4-FLAG expression. A fraction of this Pth4-FLAG protein was
imported into mitochondria and the size of the detected protein sug-
gested that the presequence had been cleaved (see Fig. S4).The cell line expressing Pth4-FLAG was used to determine if the
protein was associated with the human mitochondrial ribosome.
TransfectedHEK293T cells were induced for three days to express either
the Pth4-FLAG, or ICT1-FLAG, mitochondria were purified and treated
with DNase 1 and proteinase K to minimize unspecific contamination
from cytosolic proteins. The mitochondria were lysed and immunopre-
cipitations performed with anti-FLAG antibodies; the eluates were
then analyzed by PAGE, silver staining and western blot. The results in
Fig. 7A show different elution patterns for ICT1 control versus Pth4-
FLAG immunoprecipitate, where there are fewer and less proteins.
When examined by western blot (Fig. 7B) the levels of the FLAG tagged
proteins were similar in both eluates allowing semi-quantitative com-
parisons of co-immunoprecipitating proteins to bemade. The large ribo-
somal subunit proteins MRPL3 and MRPL12, and the small ribosomal
subunit protein DAP3 were detected but at lower levels than in the
ICT1 control IP. MRPS18B was present but at slightly elevated levels in
the Pth4-FLAG eluate while the endogenous ICT1 was not detectable.
This suggests that Pth4 from S. pombe can interact with human
mitoribosomal proteins, but that the interaction is weaker and different
to that of the endogenous ICT1.
In humanmitochondria, when ICT1 is depleted there is a conforma-
tional change in the 39S large ribosomal subunit, resulting in a shift of
MRPL3 (a protein of the large ribosomal subunit) from fractions 6/7,
BA ICT1-
FLAG
Pth4-
FLAG
ICT1-
FLAG
Pth4-
FLAG
Fig. 7. S. pombe Pth4-FLAG is able to immunoprecipitate a subset of human
mitoribosomal proteins. HEK293T-ICT1-FLAG and HEK293T-Pth4-FLAG cell lines
were induced for 3 days with 1 μg/ml tetracycline. Mitochondria were purified and
lysed, the lysates were then used for immunoprecipitation via the FLAG tag. 10% of
the elution fractions were analyzed by PAGE and western blot. A. Silver staining of
the 15% PAGE of the elution fractions, * indicates the FLAG tagged protein. B. Western
blot analysis using antibodies against ICT1 and other large subunit ribosomal (MRPL3,
MRPL12) or small subunit (DAP3 and MRPS18B) ribosomal proteins from human mi-
tochondria was performed to determine the relative level of ribosomal proteins
immunoprecipitated by Pth4-FLAG and ICT1-FLAG. To verify the presence of the
FLAG tagged protein in each elution fraction FLAG antibodies were also applied.
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Pth4-FLAG can suppress this phenotype, HEK293T-wt and HEK293T-
Pth4-FLAG cells were treated with either a control (si-NT) or an ICT1
(si-ICT1) siRNAs for three days, with concomitant tetracycline treat-
ment to induce Pth4 expression in the relevant cell line. Cells were
then harvested and lysed, and 700 μg of each sample separated on
10–30% isokinetic sucrose gradients. The isolated fractions were ana-
lyzed by western blot. In the HEK293T-wt cells treated with si-NT
(Fig. 8A, upper panel), ICT1 was present principally in fraction 6, co-
sedimenting with MRPL3 (fractions 6/7), whereas DAP3, a member of
the small ribosomal subunit was present in fractions 4 and 5. The si-
NT treated HEK293T-Pth4-FLAG cells showed a similar result (Fig. 8A,
lower panel). Upon depletion of ICT1 (Fig. 8B), ICT1 was no longer de-
tectable and MRPL3 was now detected in fraction 5, with no difference
between the HEK293T-wt and HEK293T-Pth4-FLAG cells (Fig. 8B,
upper/lower panels); thus Pth4-FLAG is not able to suppress the ICT1
depletion phenotype. Significantly, in both experiments Pth4-FLAG
wasmainly detected in fractions 1–3 and not fractions 5 or 6, consistent
with the previous data suggesting that Pth4-FLAG is not associatedwith
the large ribosomal subunit, even when mitoribosomes are depleted of
ICT1.IC
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Fig. 8. Pth4-FLAG cannot suppress the mitoribosomal defect caused by ICT1 depletion. Both H
3 days. At the same time the cultures were treated with tetracycline to induce the FLAG ta
10–30% isokinetic sucrose gradients. The fractions 1–10 were analyzed by western blotting usin
somal profile in each sample was determined using anti-MRPL3 and anti-DAP3 antibodies and4. Discussion
The orderly termination of translation is a key step in the quality con-
trol and overall process of protein synthesis. In the S. pombe mitochon-
drial system, homology searches have identified a single class I release
factor, Mrf1, but deletion of the corresponding gene only leads to a par-
tial respiratory deficiency (Soleimanpour-Lichaei et al., 2007 and Fig. 4B).
At present, it has not been definitively demonstrated that Mrf1 is a re-
lease factor, but we have shown that it is important for mitochondrial
translation (Fig. 5B) and Soleimanpour-Lichaei et al. (2007) have
shown that human mtRF1a, which recognizes the stop codons UAA
and UAG, is able to complement the Δmrf1mutation in both S. cerevisiae
and S. pombe. Thus, the evidence strongly suggests that Mrf1 is a mito-
chondrial release factor; however, the partial phenotype of the Δmfr1
strain implies that least one other protein can also act as a release factor.
Class I release factors are essentially tRNA mimics (Moffat and Tate,
1994) with conserved GGQ and decoding motifs (tip of α-5 helix and
PXT) that interact with the same centers in the A site of the ribosome
as the CCA and anticodon loop of the tRNA (see Youngman et al., 2008
for a review). Pth3 and 4 also contain the conserved GGQ motif and
modeling of this domain indicates that it has a similar structure to the
equivalent domain in Mrf1 (shown for Pth4 in Fig. S5). However, both
proteins are considerably smaller thanMrf1 and notably do not contain
an equivalent to either theα-5 helix or the PXTmotif found inMrf1.We
have undertaken a preliminary investigation of Pth3 and 4 and their
possible functional overlap with Mrf1.
We have shown that Pth3 and Pth4 are both mitochondrial proteins
that co-sediment with the large ribosomal subunit and the assembled
ribosome in yeast. The deletion of pth4 gives no obvious phenotype,
while the deletion of pth3 gives aweak respiratory phenotype that is ex-
acerbated in the double deletion strain. The respiratory phenotype of
the Δpth3, Δpth4 double mutant is however still relatively mild (see
Fig. 4). Although it is tempting to speculate that this indicates some
sort of functional overlap between Pth3 and Pth4, in reality, this is far
from clear considering that the phenotype is weak and that over-
expression of pth4 in the Δpth3 strain does not improve the respiratory
phenotype (data not shown).
The situation ismore straightforwardwhenwe examine the interac-
tions between the pth genes andmrf1. Our results give no indication of
an interaction between pth3 and mrf1; however, it is clear that there is
some interaction between pth4 and mrf1. Over-expression of pth4 in a
Δmfr1 strain increases the level of de novo translation and results in
considerably improved respiratory growth, while deletion of pth4 sig-
nificantly exacerbates the Δmfr1 phenotype. In a wild type background
the Δpth4, Δmrf1 double mutant is essentially unviable, and in a ptp1-1
background it undergoes depletion of mitochondrial DNA (Figs. 4
and 5), characteristic of impaired mitochondrial translation (ChironT1
PL3
P3
T1
L3
P3
4
B
EK293T-WT and HEK293T-Pth4-FLAG cells were treated with si-NT (A), or si-ICT1 (B) for
gged protein. Cells were then harvested and lysed. Lysates (700 μg) were separated on
g anti-ICT1 antibodies to confirm ICT1 depletion in the siRNA targeted samples. The ribo-
the distribution of Pth4-FLAG was determined by using anti-FLAG antibodies.
879L. Dujeancourt et al. / Mitochondrion 13 (2013) 871–880et al., 2005). Thus, we conclude that in the absence of Mfr1, Pth4 is able
to act as a release factor.
In humans, C12orf65 and ICT1 are orthologs of Pth3 and Pth4 respec-
tively, and both have been shown to be important for mitochondrial
translation. Depletion of C12orf65 reduces complex IV activity by
about 50% but has a less dramatic effect than depletion of ICT1
(Kogure et al., 2012). ICT1 has been shown to be a constituent of the
large ribosomal subunit and intact mitoribosomes, with a codon inde-
pendent Pth activity (Richter et al., 2010). We have shown that when
expressed in S. pombe neither C12orf65 nor ICT1 can complement the
respiratory deficiency of a Δmrf1 strain (the phenotype of the Δpth3
strain is not sufficiently strong to allow meaningful complementation
experiments). Further, when Pth4 is expressed inHEK293T cells, in con-
trast to control FLAG IP with mitochondrially targeted luciferase
(Richter et al., 2010; Rorbach et al., 2008), it is able to immunoprecipi-
tate (IP) a number of mitoribosomal proteins, although not endogenous
ICT1. This together with the gradient data suggest that the interaction of
Pth4 with the human mitochondrial ribosome is not the same as ICT1
that integrates into the mitoribosome, and is probably via access to
the free A-site. This is consistent with the inability to suppress the con-
formation change that occurs in the large ribosomal subunit upon ICT1
depletion (Figs. 7 and 8). Pth4 therefore cannot functionally replace
ICT1.
In S. cerevisiae, Mrf1 is essential for mitochondrial translation and the
maintenance of themitochondrial genome even though S. cerevisiae con-
tains a sequence homolog of Pth4 (Yol114c). The reason for this differ-
ence between S. cerevisiae on the one hand and S. pombe and man, on
the other is not clear. A possible explanation is that S. cerevisiae mito-
chondrial mRNAs have long 3′ UTRs, while both S. pombe and man
have very short, or nonexistent 3′ UTRs. In S. pombe the mature 3′ ends
of the mitochondrial transcripts are produced by Pah1 and Par1, in the
absence of either of these proteins, mitochondrial mRNAs with long
unprocessed 3′ UTRs accumulate (Hoffmann et al., 2008). Interestingly,
Δpah1 and Δmrf1 are essentially co-lethal (Fig. S6), which could suggest
that the presence of a long 3′ UTR reduces the effectiveness of Pth4.
We have shown that the over-expression of pth4 can partially sup-
press the phenotypes associated with the deletion of mrf1. Multi-copy
suppressors can act in a variety of ways, either indirect or direct; for ex-
ample, an excess of Pth4 could enhance the activity of another protein
that compensates for the absence of Mrf1. However, considering the
co-sedimentation of Pth4 with the large subunit of the mt ribosome
and its structural similarity to Mrf1, we think it's more probable that
Pth4 is able to act as a release factor, at least in the absence of mrf1,
but it is not clear if this is part of the normal role of Pth4 in the wild
type cell. While Pth3, Pth4 and Mrf1 all appear to be able to associate
with the large ribosomal subunit as part of the fully assembled ribo-
some, it is not known whether different factors can be present on the
same ribosome, or if the different factors define subpopulations of “dif-
ferent”mitoribosomes. Further experiments will be necessary to clarify
the roles of the different release factors.Acknowledgments
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